Losartan improves alveolar bone dynamics in normotensive rats but not in hypertensive rats

Abstract Hypertension is one of the main causes of premature death in the world; also, it is associated with several bone alterations. Preclinical studies have demonstrated delayed alveolar bone healing in hypertensive rats. However, losartan has been favorable for consolidation of bone grafts and r...

Full description

Bibliographic Details
Main Authors: Gabriel Mulinari-Santos, Jaqueline Silva dos Santos, Letícia Pitol Palin, Ana Cláudia Ervolino da Silva, Cristina Antoniali, Leonardo Perez Faverani, Roberta Okamoto
Format: Article
Language:English
Published: University of São Paulo
Series:Journal of Applied Oral Science
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1678-77572019000100479&lng=en&tlng=en
_version_ 1818060375510220800
author Gabriel Mulinari-Santos
Jaqueline Silva dos Santos
Letícia Pitol Palin
Ana Cláudia Ervolino da Silva
Cristina Antoniali
Leonardo Perez Faverani
Roberta Okamoto
author_facet Gabriel Mulinari-Santos
Jaqueline Silva dos Santos
Letícia Pitol Palin
Ana Cláudia Ervolino da Silva
Cristina Antoniali
Leonardo Perez Faverani
Roberta Okamoto
author_sort Gabriel Mulinari-Santos
collection DOAJ
description Abstract Hypertension is one of the main causes of premature death in the world; also, it is associated with several bone alterations. Preclinical studies have demonstrated delayed alveolar bone healing in hypertensive rats. However, losartan has been favorable for consolidation of bone grafts and reduction in active periodontitis. Therefore, losartan is suggested to be effective in bone formation stages, as well as in the synthesis of matrix proteins and mineralization. Objectives: To evaluate the alveolar bone dynamics in hypertensive rats treated with losartan by laser confocal microscopy and histological analysis. Methodology: Thirty-two rats, 16 spontaneously hypertensive rats (SHR) and 16 Wistar albinus rats, treated or not with losartan (30 mg/kg/day) were used. Calcein fluorochrome at 21 days and alizarin red fluorochrome at 49 days were injected in rats (both 20 mg/kg). The animals were submitted to euthanasia 67 days after treatment, and then the right maxilla was removed for laser confocal microscopy analysis and the left maxilla for histological analysis. Results: This study showed a greater calcium marking in normotensive animals treated with losartan in relation to the other groups. Laser confocal microscopy parameters showed higher values of bone volume formed, mineralized surface, active surface of mineralization and bone formation rate in normotensive animals treated with losartan. However, a smaller mineralized surface was observed in all hypertensive animals. Conclusion: Losartan can improve bone mineralization parameters under normal physiological conditions, but the same anabolic effect does not occur under hypertension.
first_indexed 2024-12-10T13:31:25Z
format Article
id doaj.art-67c462827db34c2ead894bd96c149e34
institution Directory Open Access Journal
issn 1678-7765
language English
last_indexed 2024-12-10T13:31:25Z
publisher University of São Paulo
record_format Article
series Journal of Applied Oral Science
spelling doaj.art-67c462827db34c2ead894bd96c149e342022-12-22T01:46:57ZengUniversity of São PauloJournal of Applied Oral Science1678-77652710.1590/1678-7757-2018-0574S1678-77572019000100479Losartan improves alveolar bone dynamics in normotensive rats but not in hypertensive ratsGabriel Mulinari-SantosJaqueline Silva dos SantosLetícia Pitol PalinAna Cláudia Ervolino da SilvaCristina AntonialiLeonardo Perez FaveraniRoberta OkamotoAbstract Hypertension is one of the main causes of premature death in the world; also, it is associated with several bone alterations. Preclinical studies have demonstrated delayed alveolar bone healing in hypertensive rats. However, losartan has been favorable for consolidation of bone grafts and reduction in active periodontitis. Therefore, losartan is suggested to be effective in bone formation stages, as well as in the synthesis of matrix proteins and mineralization. Objectives: To evaluate the alveolar bone dynamics in hypertensive rats treated with losartan by laser confocal microscopy and histological analysis. Methodology: Thirty-two rats, 16 spontaneously hypertensive rats (SHR) and 16 Wistar albinus rats, treated or not with losartan (30 mg/kg/day) were used. Calcein fluorochrome at 21 days and alizarin red fluorochrome at 49 days were injected in rats (both 20 mg/kg). The animals were submitted to euthanasia 67 days after treatment, and then the right maxilla was removed for laser confocal microscopy analysis and the left maxilla for histological analysis. Results: This study showed a greater calcium marking in normotensive animals treated with losartan in relation to the other groups. Laser confocal microscopy parameters showed higher values of bone volume formed, mineralized surface, active surface of mineralization and bone formation rate in normotensive animals treated with losartan. However, a smaller mineralized surface was observed in all hypertensive animals. Conclusion: Losartan can improve bone mineralization parameters under normal physiological conditions, but the same anabolic effect does not occur under hypertension.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1678-77572019000100479&lng=en&tlng=enLosartanSpontaneously hypertensive ratsBoneHypertension
spellingShingle Gabriel Mulinari-Santos
Jaqueline Silva dos Santos
Letícia Pitol Palin
Ana Cláudia Ervolino da Silva
Cristina Antoniali
Leonardo Perez Faverani
Roberta Okamoto
Losartan improves alveolar bone dynamics in normotensive rats but not in hypertensive rats
Journal of Applied Oral Science
Losartan
Spontaneously hypertensive rats
Bone
Hypertension
title Losartan improves alveolar bone dynamics in normotensive rats but not in hypertensive rats
title_full Losartan improves alveolar bone dynamics in normotensive rats but not in hypertensive rats
title_fullStr Losartan improves alveolar bone dynamics in normotensive rats but not in hypertensive rats
title_full_unstemmed Losartan improves alveolar bone dynamics in normotensive rats but not in hypertensive rats
title_short Losartan improves alveolar bone dynamics in normotensive rats but not in hypertensive rats
title_sort losartan improves alveolar bone dynamics in normotensive rats but not in hypertensive rats
topic Losartan
Spontaneously hypertensive rats
Bone
Hypertension
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1678-77572019000100479&lng=en&tlng=en
work_keys_str_mv AT gabrielmulinarisantos losartanimprovesalveolarbonedynamicsinnormotensiveratsbutnotinhypertensiverats
AT jaquelinesilvadossantos losartanimprovesalveolarbonedynamicsinnormotensiveratsbutnotinhypertensiverats
AT leticiapitolpalin losartanimprovesalveolarbonedynamicsinnormotensiveratsbutnotinhypertensiverats
AT anaclaudiaervolinodasilva losartanimprovesalveolarbonedynamicsinnormotensiveratsbutnotinhypertensiverats
AT cristinaantoniali losartanimprovesalveolarbonedynamicsinnormotensiveratsbutnotinhypertensiverats
AT leonardoperezfaverani losartanimprovesalveolarbonedynamicsinnormotensiveratsbutnotinhypertensiverats
AT robertaokamoto losartanimprovesalveolarbonedynamicsinnormotensiveratsbutnotinhypertensiverats